Search Results for

EA8211

Phase III Randomized Trial of Stereotactic Ablative Radiotherapy (SAbR) for Oligometastatic Advanced Renal Carcinoma (SOAR)

Continue Reading »

---

S2200

A Phase II Randomized Trial of Cabozantinib (NSC #761968) with or Without Atezolizumab (NSC #783608) in Patients with Advanced Papillary Renal Cell Carcinoma (PAPMET2)

Continue Reading »

---

A031704

PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab Vs. VEGF TKI Cabozantinib with Nivolumab: A Phase III Trial in Metastatic Untreated REnal Cell CancEr [PDIGREE]

Continue Reading »

---

Search Again

• All Trial Categories Amyloidosis  (1) Anal  (1) Bladder/Urinary Tract Cancer  (7)    Adjuvant  (1)    Metastatic  (3)    Neoadjuvant  (1) Brain  (7)    Glioblastoma Multiforme (GBM)  (1)    Other Brain Tumors  (3) Breast  (14)    Breast Cancer Adjuvant  (1)    Breast Cancer Neoadjuvant  (2) Cancer Control/Symptom Management  (21) Carcinoid Tumors  (2) Colorectal Cancer  (7)    Metastatic  (1)    Rectal Neoadjuvant  (1) Esophageal Cancer  (3) Gastric Cancer  (3) Head/Neck Cancer  (8) Leukemia  (1) Lung Cancer  (18)    Non-Small Cell Lung Cancer  (14)       1st Line Metastatic, Stage3b with Maligned Effusion or Stage 4 Disease at Presentation or Recurrence  (2)       Adjuvant Treatment for Resected NSCLC  (2)    Small Cell Lung Cancer  (3)       Extensive Stage SCLC  (1) MATCH Trial  (3) Melanoma  (2) Merkel Cell Carcinoma  (1) Misc. Gynecology  (3) Multiple Myeloma  (2) Ovarian  (2) Pancreatic  (7)    Metastatic Disease  (1) Prostate  (8) Renal Cell/Kidney Cancer  (3)    Locally Advanced/Metastatic  (1) Sarcoma  (1)